{"id":"doi:10.1038/nrclinonc.2016.58","kind":"review","title":"Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination","authors":["C. Boutros","Ahmad A. Tarhini","Émilie Routier","Olivier Lambotte","François Le Roy Ladurie","Franck Carbonnel","Hassane Izzeddine","Aurélien Marabelle","Stéphane Champiat","Armandine Berdelou","Émilie Lanoy","Matthieu Texier","Cristina Libenciuc","Alexander M.M. Eggermont","Jean‐Charles Soria","Christine Mateus","Caroline Robert"],"author_count":17,"year":2016,"published":"2016-05-04","venue":"Nature Reviews Clinical Oncology","cited_by":1101,"doi":"10.1038/nrclinonc.2016.58","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/nrclinonc.2016.58","archive_url":"https://space-kitty.com/papers/doi:10.1038/nrclinonc.2016.58","updated":null,"pmid":"27141885","pmcid":null,"openalex_id":"W2347141054","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}